Stock Fundamentals

Company Information

Company Name
Aurinia Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA05156V1022
CIK: 0001600620
CUSIP: 05156V102
Currency: USD
Full Time Employees: 128
Phone: 250 744 2487
Fiscal Year End: December
IPO Date: Jan 26, 1999
Description:

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

Address:

#140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6

Directors & Officers

Name Title Year Born
Mr. Peter S. Greenleaf M.B.A. President, CEO & Director 1970
Mr. Matthew Maxwell Donley M.B.A. Chief Operations Officer 1969
Mr. Stephen P. Robertson Executive VP, General Counsel, Corporate Secretary & Chief Compliance Officer 1983
Dr. Gregory F. Keenan M.D. Senior VP & Chief Medical Officer 1962
Mr. Michael Gammons Vice President & Chief Information Officer NA
Ms. Andrea Levin Christopher Executive Director of Corporate Communications & Investor Relations NA
Mr. Richard Lewis Vice President of Sales NA
Mr. Eric Victory Vice President of Corporate Development NA
Ms. Lucy Shieh Vice President of Human Resources & Operations NA
Dr. Premchandran Ramiya Ph.D. Senior Vice President of Manufacturing & Supply Chain 1961

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
TANG CAPITAL MANAGEMENT LLC 11.33M Sep 30, 2025 8.56% $4.82 12.96%
BlackRock Inc 7.45M Sep 30, 2025 5.63% $0.00 -3.18%
NEA Management Company, LLC 3.97M Dec 31, 2025 3.00% $3.23 0.00%
Arrowstreet Capital Limited Partnership 3.39M Dec 31, 2025 2.56% $0.03 0.39%
State Street Corp 2.69M Sep 30, 2025 2.04% $0.00 -3.63%
Two Sigma Investments LLC 1.96M Dec 31, 2025 1.48% $0.04 46.36%
Morgan Stanley - Brokerage Accounts 1.95M Sep 30, 2025 1.47% $0.00 -18.76%
Renaissance Technologies Corp 1.59M Dec 31, 2025 1.20% $0.04 9.69%
D. E. Shaw & Co LP 1.53M Dec 31, 2025 1.16% $0.01 68.40%
Geode Capital Management, LLC 1.49M Sep 30, 2025 1.12% $0.00 -5.79%
Marshall Wace Asset Management Ltd 1.48M Sep 30, 2025 1.12% $0.02 1,272.51%
Vanguard Group Inc 1.45M Dec 31, 2025 1.10% $0.00 -6.91%
Two Sigma Advisers, LLC 1.31M Dec 31, 2025 0.99% $0.04 172.10%
Qube Research & Technologies 1.15M Sep 30, 2025 0.87% $0.01 -7.22%
Jacobs Levy Equity Management, Inc. 1.14M Dec 31, 2025 0.86% $0.07 -6.58%
JPMorgan Chase & Co 1.07M Sep 30, 2025 0.81% $0.00 143.32%
HHG PLC 1.04M Sep 30, 2025 0.79% $0.01 369.96%
Jupiter Asset Management Limited 899.48K Dec 31, 2025 0.68% $0.11 9.22%
Northern Trust Corp 896.45K Sep 30, 2025 0.68% $0.00 -2.69%
Man Group PLC 852.67K Dec 31, 2025 0.64% $0.02 368.86%

Shares Statistics

Shares Outstanding: 131.84M
Shares Float: 128.19M
% Insiders: 681.60%
% Institutions: 5,562.80%
Short % Float: 7.86%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 TANG CAPITAL MANAGEMENT LLC 11.33M 8.56% ▲ 12.96% Sep 30, 2025
2 BlackRock Inc 7.45M 5.63% ▼ 3.18% Sep 30, 2025
3 NEA Management Company, LLC 3.97M 3.00% ▲ 0.00% Dec 31, 2025
4 Arrowstreet Capital Limited Partnership 3.39M 2.56% ▲ 0.39% Dec 31, 2025
5 State Street Corp 2.69M 2.04% ▼ 3.63% Sep 30, 2025
6 Two Sigma Investments LLC 1.96M 1.48% ▲ 46.36% Dec 31, 2025
7 Morgan Stanley - Brokerage Accounts 1.95M 1.47% ▼ 18.76% Sep 30, 2025
8 Renaissance Technologies Corp 1.59M 1.20% ▲ 9.69% Dec 31, 2025
9 D. E. Shaw & Co LP 1.53M 1.16% ▲ 68.40% Dec 31, 2025
10 Geode Capital Management, LLC 1.49M 1.12% ▼ 5.79% Sep 30, 2025

Valuation Metrics

Enterprise Value: $1.59B
Trailing P/E: 25.30
Forward P/E: 18.59

Financial Highlights

Market Cap: $1.87B
EBITDA: $135.71M
P/E Ratio: $25.30
PEG Ratio: $0.00
Book Value: $4.39
Earnings/Share: $0.56
Profit Margin: 101.47%
Operating Margin: 55.68%
ROA (TTM): 11.16%
ROE (TTM): 59.91%
Revenue (TTM): $283.06M
Revenue/Share (TTM): $2.11
Earnings Growth (YOY): 15,073.20%
Revenue Growth (YOY): 28.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.25x 0.03x 0.23x 24.23x 0.14x
2024-12-31 4.57x 0.04x 0.31x -0.97x 0.48x
2023-12-31 5.50x 0.04x 0.31x -33.04x -0.25x
2022-12-31 9.60x 0.00x 0.14x -21.78x -0.01x
2021-12-31 12.63x 0.00x 0.12x -341.65x -0.01x
2020-12-31 13.11x 0.00x 0.12x -19.70x -0.01x
2019-12-31 27.90x 0.02x 0.08x -2,331.87x -0.08x
2018-12-31 18.30x 0.00x 0.23x -25.14x 0.00x
2017-12-31 21.50x 0.10x 0.13x -67.04x -0.35x
2016-12-31 5.22x 0.34x 0.37x -844.96x -0.57x
2015-12-31 4.57x 0.28x 0.41x -471.60x -0.25x
2014-12-31 11.83x 0.25x 0.14x -576.07x -0.72x
2013-12-31 0.35x 0.10x 0.43x -53.45x -0.23x
2012-12-31 0.12x -0.83x 1.51x -54.12x -0.20x
2011-12-31 3.91x 0.02x 0.55x -6,574.01x -0.07x
2010-12-31 4.90x 0.00x 0.38x -420.59x 0.00x
2009-12-31 1.67x 0.00x 0.50x -9.77x 0.00x
2008-12-31 2.38x 1.64x 0.70x -19.36x -0.91x
2007-12-31 3.29x 0.02x 0.33x -254.82x -0.02x
2006-12-31 3.41x 0.12x 0.34x -89.95x -0.10x
2005-12-31 4.91x 0.09x 0.22x -79.41x -0.14x
2004-12-31 9.93x 0.09x 0.15x N/A -0.23x
2003-12-31 11.96x 0.01x 0.08x -323.25x -0.04x
2002-12-31 14.65x 0.01x 0.06x N/A -0.30x
2001-12-31 20.31x 0.00x 0.05x N/A -0.02x
2000-12-31 10.94x 0.01x 0.09x -449.92x -0.02x
1999-12-31 3.46x 0.02x 0.23x N/A -0.06x
1998-12-31 0.25x -0.23x 1.54x N/A -0.10x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 05, 2025 Kevin Tang N/A Purchase 200.00K $11.68 $2.34M
Aug 04, 2025 Kevin Tang N/A Purchase 100.00K $11.34 $1.13M
Aug 01, 2025 Kevin Tang N/A Purchase 1.00M $10.12 $10.12M
Mar 07, 2025 Greg Keenan N/A Sale 8.31K $8.23 $68.35K
Mar 03, 2025 Greg Keenan N/A Sale 12.24K $8.00 $97.91K
Mar 03, 2025 Joseph M Miller N/A Sale 61.86K $8.00 $494.87K
Mar 03, 2025 Matthew Maxwell Donley N/A Sale 65.90K $8.00 $527.22K
Mar 03, 2025 Peter Greenleaf N/A Sale 195.59K $8.00 $1.56M

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about AUPH.US!